Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
129.11
+1.77 (1.39%)
At close: Jun 17, 2026, 4:00 PM EDT
133.10
+3.99 (3.09%)
After-hours: Jun 17, 2026, 7:58 PM EDT

Guardant Health Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, Guardant Health stock has a consensus rating of "Strong Buy" and an average price target of $140.91. The average 1-year stock price forecast is 9.14% higher than the current stock price, while the lowest is $90 (-30.29%) and the highest is $190 (+47.16%).

Price Target: $140.91 (+9.14%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$90$140.91$135$190
Change-30.29%+9.14%+4.56%+47.16%

Analyst Ratings

The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy161716161618
Buy555445
Hold122210
Sell000011
Strong Sell100000
Total232423222224

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Initiates
$185
BuyInitiates$185+43.29%Jun 11, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$135$175
BuyMaintains$135$175+35.54%Jun 8, 2026
Goldman Sachs
Goldman Sachs
Buy
Initiates
$165
BuyInitiates$165+27.80%Jun 5, 2026
Evercore ISI
Evercore ISI
Buy
Upgrades
$95$160
BuyUpgrades$95$160+23.93%Jun 2, 2026
Leerink Partners
Leerink Partners
Buy
Reiterates
n/a
BuyReiteratesn/an/aJun 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.31B
from 982.02M
Increased by 33.82%
Revenue Next Year
1.70B
from 1.31B
Increased by 29.36%
EPS This Year
-1.42
from -1.82
EPS Next Year
-0.53
from -1.42
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
373.65M449.54M563.95M739.02M982.02M1.31B
Revenue Growth
30.32%20.31%25.45%31.04%32.88%33.82%
Gross Profit
250.74M293.21M336.90M449.22M633.01M849.27M
Gross Margin
67.11%65.23%59.74%60.79%64.46%64.63%
Operating Income
-411.00M-544.38M-481.22M-442.58M-436.30M-376.50M
Net Income
-405.67M-654.59M-479.45M-436.37M-416.28M-379.95M
EPS
-----1.82-1.42
Free Cash Flow
-123.48M-295.57M-180.70M-148.78M-88.11M-206.37M
No. Analysts
-----23
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.3B
Avg1.3B
Low1.3B

Revenue Growth

Revenue Growth202620272028
High
34.5%
Avg
33.8%
Low
32.7%

EPS Forecast

EPS202620272028
High-1.25
Avg-1.42
Low-1.76

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-